A proof-of-concept study of Ga-68-TATE-RGD PET/CT for duel-target imaging of somatostatin receptor and integrin alpha(v)beta(3) to detect lung cancer and neuroendocrine tumor in a single scan
第一作者单位：[1]Peking Union Medical College Hospital, Beijing, CHINA,[2]China- Japan Friendship Hospital, Beijing, CHINA.
推荐引用方式(GB/T 7714)：
Y. Zheng,H. Wang,X. Cui,et al.A proof-of-concept study of Ga-68-TATE-RGD PET/CT for duel-target imaging of somatostatin receptor and integrin alpha(v)beta(3) to detect lung cancer and neuroendocrine tumor in a single scan[J].EUROPEAN JOURNAL of NUCLEAR MEDICINE and MOLECULAR IMAGING.2017,44:S149-S149.
APA：
Y. Zheng,H. Wang,X. Cui,L. Zhang,H. Tan...&Z. Zhu.(2017).A proof-of-concept study of Ga-68-TATE-RGD PET/CT for duel-target imaging of somatostatin receptor and integrin alpha(v)beta(3) to detect lung cancer and neuroendocrine tumor in a single scan.EUROPEAN JOURNAL of NUCLEAR MEDICINE and MOLECULAR IMAGING,44,
MLA：
Y. Zheng,et al."A proof-of-concept study of Ga-68-TATE-RGD PET/CT for duel-target imaging of somatostatin receptor and integrin alpha(v)beta(3) to detect lung cancer and neuroendocrine tumor in a single scan".EUROPEAN JOURNAL of NUCLEAR MEDICINE and MOLECULAR IMAGING 44.(2017):S149-S149
医学